#AIEye Episode 448: ZEISS Partners (OTC: $CZMWF) with Microsoft (NasdaqGS: $MSFT) for Digital Cloud Transformation, NVIDIA (NasdaqGS: $NVDA) Partners with GSK (NYSE: $GSK) for AI-Powered Discovery of Medicines and Vaccines
Global
RPA Market to Reach $6.10 Billion by 2027
Point Roberts WA, Vancouver BC – October 7, 2020 – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye- watching stock news, deal tracker and advancements in artificial intelligence.
Listen
to today’s podcast:
https://www.investorideas.com/Audio/Podcasts/2020/100720-AI-Eye.mp3
Read
this in full at https://www.investorideas.com/news/2020/artificial-intelligence/10071AIEye-ZEISS-MSFT-NVDA-GSK.asp
Today’s
Column- The
AI Eye- Watching stock news, deal tracker and advancements
in artificial intelligence
Stocks
discussed: (OTC:CZMWF) (NasdaqGS:MSFT) (NasdaqGS:NVDA) (NYSE:GSK)
Optics and optoelectronics manufacturer ZEISS Group (OTC:CZMWF) has entered a multi-year strategic partnership
with Microsoft (NasdaqGS:MSFT) to accelerate its
transformation into a digital services provider with a cloud first approach. In
doing so, according to the press release, ZEISS will leverage Microsoft Azure’s
“high-performance compute, AI, and IoT services,” “to provide original
equipment manufacturers (OEMs) with new quality management solutions, enable
microchip manufacturers to build more powerful, energy-efficient microchips,
and deliver new digital healthcare solutions for improved clinical workflows,
enhanced treatments, and device maintenance.” Karl Lamprecht, ZEISS President
and CEO, commented:
"As
a global leader in optics and optoelectronics, ZEISS is committed to digitally
enable its customers' business models, products, and services. We are proud to
join forces with Microsoft in our quest to apply precision optics, IoT
capabilities, artificial intelligence and machine learning to the most
demanding processes in healthcare and manufacturing. Improving the patient's
life and doctor's work and driving industrial quality assurance in the
production process have always been top of mind for us. We are taking our
expertise to the next digital level together with Microsoft, a leading
innovator and provider of digital technologies."
NVIDIA Corporation (NasdaqGS:NVDA) has announced a partnership with healthcare and
pharmaceutical giant GlaxoSmithKline (NYSE:GSK) and its recently-established
London-based AI hub, to aid in the discovery of medicines and vaccines. Kim
Branson, senior vice president and global head of AI and ML at GSK, said:
“Because
of the massive size of the datasets we use for drug discovery, we need to push
the boundaries of hardware and develop new machine learning software. We’re
building new algorithms and approaches in addition to bringing together the
best minds at the intersection of medicine, genetics and artificial
intelligence in the U.K.’s rich ecosystem. This new partnership with NVIDIA
will also contribute additional computational power and state-of-the-art AI
technology.”
Global
RPA Market to Reach $6.10 Billion by 2027
A report published by Fortune Business Insights finds that the
global Robotic Process Automation (RPA) market will grow from $1.03 billion in
2019 to $6.10 billion by 2027 with a compound annual growth rate (CAGR) of 24.9
percent in the forecast period 2020-2027. The following excerpt from the report
summary outlines the role of AI adoption in driving the market:
Robotic
process automation is in demand by organizations to handle complex unstructured
information and automate any business functionality from end to end. Companies
are combining artificial intelligence as well as cognitive technologies with
RPA to extend the horizons of business process automation. These tools
automatically observe the work activities, recognize optimal workflows, and
suggest an automation path to the business.
RPA
combined with artificial intelligence access unstructured information such as
audio, video, and human chat conversation to make end-to-end automation
possible.
Sam Mowers, Investorideas.com
Read and
hear other editions of the AI Eye
For a list of
artificial intelligence stocks on Investorideas.com visit
here
Investors can
trade these stocks and other ideas on
our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.
About Investorideas.com - News that Inspires Big
Investing Ideas Investorideas.com is a recognized news source publishing third party
news, research and original financial content. Learn about investing in stocks
and sector trends with our news alerts, articles, podcasts and videos,
looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas Potcasts Cannabis News
and Stocks on the Move podcast and column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
The
Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com,
iHeartRadio and Google Play Music.
Visit the Podcast
page at Investorideas.com:
https://www.investorideas.com/Audio/
Disclaimer/Disclosure: Investorideas.com is a digital publisher of
third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investing involves risk
and possible losses. This site is currently compensated for news publication
and distribution, social media and marketing, content creation and more.
Disclosure is posted for each compensated news release, content published
/created if required but otherwise the news was not compensated for and was
published for the sole interest of our readers and followers. Contact
management and IR of each company directly regarding specific questions. More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about
publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com Global investors
must adhere to regulations of each country. Please read Investorideas.com
privacy policy: https://www.investorideas.com/About/Private_Policy.asp
The AI Eye-
Watching stock news, deal tracker and advancements in artificial
intelligence is an original content brand of Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile
App for iPhone and
Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Technology stock investor
ideas - news, articles, podcasts and stock directories
No comments:
Post a Comment